Why the study?
Does AAV2/5 hybrid vector improve muscle-directed gene transfer transduction efficacy compared to AAV2 in immune-competent mice?
Does AAV2/5 hybrid vector improve muscle-directed gene transfer transduction efficacy compared to AAV2 in immune-competent mice?
AAV2/5 hybrid vectors demonstrate superior muscle-directed gene transfer efficacy compared to AAV2 in mice, and humans lack pre-existing immunity to AAV5 capsids, suggesting potential for clinical gene therapy.
Answers are grounded in this paper and cite their sources.
May enhance muscle gene transfer in immune-competent models; leaves open clinical translation of AAV2/5.
Vectors based on hybrids consisting of adeno-associated virus types 2 (ITRs and Rep) and 5 (Cap) were evaluated for muscle-directed gene transfer (called AAV2/5). Evaluation in immune-competent mice revealed greater transduction efficacy with AAV2/5 than with AAV2 and no cross-neutralization between AAV2/5 and AAV2. Interestingly, we saw no immunologic evidence of previous exposure to AAV5 capsids in a large population of healthy human subjects.
No takes yet. Share an insight, caveat, or question.
Hildinger et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: